Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04880863
What this trial is testing

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
NeoTX Therapeutics Ltd. 38
Testing effectiveness (Phase 2)UnknownNCT04425681
What this trial is testing

Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer

Who this might be right for
Leptomeningeal MetastasisNon-small Cell Lung CancerEGFR Activating Mutation
Second Affiliated Hospital of Nanchang University 20
Testing effectiveness (Phase 2)Study completedNCT00702975
What this trial is testing

Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy

Who this might be right for
Locally Advanced Non-Small Cell Lung CancerNSCLC
Radboud University Medical Center 35
Large-scale testing (Phase 3)Study completedNCT04205812
What this trial is testing

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Non-Small Cell Lung CancerMetastatic Nonsquamous Non-Small Cell Lung Cancer
Incyte Corporation 583
Not applicableLooking for participantsNCT05689619
What this trial is testing

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Who this might be right for
Brain Metastases, AdultNon Small Cell Lung CancerBreast Cancer
A.O.U. Città della Salute e della Scienza 70
Testing effectiveness (Phase 2)Study completedNCT02289456
What this trial is testing

Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 40
Early research (Phase 1)Not Yet RecruitingNCT07807345
What this trial is testing

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

Who this might be right for
Head & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more
Sutro Biopharma, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT02337530
What this trial is testing

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Canadian Cancer Trials Group 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04310007
What this trial is testing

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 117
Early research (Phase 1)Study completedNCT02451930
What this trial is testing

The Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC

Who this might be right for
Stage IV Non-Small Cell Lung Cancer
Eli Lilly and Company 71
Testing effectiveness (Phase 2)Ended earlyNCT01640730
What this trial is testing

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Who this might be right for
Stage IV NSCLC
KangLaiTe USA 1
Not applicableLooking for participantsNCT02838836
What this trial is testing

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerGastric Cancer+3 more
University of Missouri-Columbia 620
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Large-scale testing (Phase 3)Study completedNCT01724801
What this trial is testing

Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer

Who this might be right for
Brain MetastasisNon Small Cell Lung Cancer
Guangdong Association of Clinical Trials 176
Testing effectiveness (Phase 2)UnknownNCT04094909
What this trial is testing

Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC

Who this might be right for
Staging IV NSCLC
Guangzhou Institute of Respiratory Disease 186
Testing effectiveness (Phase 2)Looking for participantsNCT07148128
What this trial is testing

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Who this might be right for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer+2 more
Auricula Biosciences Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05091528
What this trial is testing

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

Who this might be right for
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Colorectal Cancer+1 more
Silverback Therapeutics 2
Early research (Phase 1)Ended earlyNCT02258607
What this trial is testing

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Who this might be right for
Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
Sierra Oncology LLC - a GSK company 21
Testing effectiveness (Phase 2)Study completedNCT00182806
What this trial is testing

Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 38
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Next Page
110